In melanoma models, HDAC6 inhibitors had a more significant inhibitory effect on tumor growth in C57BL/6 mice than in immunodeficient mice, which demonstrates that the antitumor effect of HDAC6 inhibitors requires an intact host immune system [9]. Here, HDAC6 is linked to neoplasm.